KAYNAKLAR
1. Cohn JR, Pizzi A. Determinants of
patient compliance with allergen immunotherapy. Journal of allergy
and clinical immunology. 1993;91(3):734-737.
2. Lower T, Henry J, Mandik L, Janosky
J, Friday Jr G. Compliance with allergen immunotherapy. Annals of
allergy. 1993;70(6):480.
3. Incorvaia C, Mauro M, Ridolo E, et
al. Patient’s compliance with allergen immunotherapy. Patient
preference and adherence. 2008;2:247.
4. Vita D, Caminiti L, Arrigo T,
Lombardo F, Incorvaia C, ni Barberio G. Children’s compliance with
allergen immunotherapy according to administration routes. Journal
of allergy and clinical immunology. 2005;116(6):1380.
5. Musa F, Al-Ahmad M, Arifhodzic N,
Al-Herz W. Compliance with allergen immunotherapy and factors affecting
compliance among patients with respiratory allergies. Human
vaccines & immunotherapeutics. 2017;13(3):514-517.
6. Cox LS, Hankin C, Lockey R. Allergy
immunotherapy adherence and delivery route: location does not matter.The Journal of Allergy and Clinical Immunology: In Practice.2014;2(2):156-160. e152.
7. De Filippo O, D’Ascenzo F, Angelini
F, et al. Reduced rate of hospital admissions for ACS during Covid-19
outbreak in Northern Italy. New England Journal of Medicine.2020.
8. Brożek JL, Bousquet J,
Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma
(ARIA) guidelines: 2010 revision. Journal of Allergy and Clinical
Immunology. 2010;126(3):466-476.
9. Pedersen SE, Hurd SS, Lemanske Jr
RF, et al. Global strategy for the diagnosis and management of asthma in
children 5 years and younger. Pediatric pulmonology.2011;46(1):1-17.
10. Bilo B, Rueff F, Mosbech H,
Bonifazi F, Oude‐Elberink J, Hypersensitivity EIGoIV. Diagnosis of
Hymenoptera venom allergy. Allergy. 2005;60(11):1339-1349.
11. Golden DB. Insect sting allergy
and venom immunotherapy: a model and a mystery. Journal of allergy
and clinical immunology. 2005;115(3):439-447.
12. Jutel M, Agache I, Bonini S, et
al. International consensus on allergy immunotherapy. Journal of
Allergy and Clinical Immunology. 2015;136(3):556-568.
13. Chaker A, Al-Kadah B, Luther U,
Neumann U, Wagenmann M. An accelerated dose escalation with a grass
pollen allergoid is safe and well-tolerated: a randomized open label
phase II trial. Clinical and translational allergy.2015;6(1):1-7.
14. Leader BA, Rotella M, Stillman L,
DelGaudio JM, Patel ZM, Wise SK. Immunotherapy compliance: comparison of
subcutaneous versus sublingual immunotherapy. Paper presented at:
International forum of allergy & rhinology2016.
15. Yang Y, Wang Y, Yang L, et al.
Risk factors and strategies in nonadherence with subcutaneous
immunotherapy: a real‐life study. Paper presented at: International
Forum of Allergy & Rhinology2018.
16. Donahue JG, Greineder DK,
Connor-Lacke L, Canning CF, Platt R. Utilization and cost of
immunotherapy for allergic asthma and rhinitis. Annals of Allergy,
Asthma & Immunology. 1999;82(4):339-347.
17. Mahesh P, Vedanthan P, Amrutha D,
Giridhar B, Prabhakar A. Factors associated with non-adherence to
specific allergen immunotherapy in management of respiratory allergy.The Indian journal of chest diseases & allied sciences.2010;52(2):91.
18. More DR, Hagan LL. Factors
affecting compliance with allergen immunotherapy at a military medical
center. Annals of Allergy, Asthma & Immunology.2002;88(4):391-394.
19. Lourenco T, Fernandes M, Coutinho
C, Lopes A, Neto M. Subcutaneous immunotherapy with aeroallergens
Evaluation of adherence in real life. European annals of allergy
and clinical immunology. 2020;52(2):84-90.
20. Gelincik A, Demir S, Olgaç M, et
al. High adherence to subcutaneous immunotherapy in a real-life study
from a large tertiary medical center. Paper presented at: Allergy &
Asthma Proceedings2017.
21. Rhodes BJ. Patient dropouts
before completion of optimal dose, multiple allergen immunotherapy.Annals of Allergy, Asthma & Immunology. 1999;82(3):281-286.
22. Çetinkaya PG, Esenboğa S, Soyer
ÖU, Tuncer A, Şekerel BE, Şahiner ÜM. Subcutaneous venom immunotherapy
in children: Efficacy and safety. Annals of Allergy, Asthma &
Immunology. 2018;120(4):424-428.
23. Gur Cetinkaya P, Kahveci M,
Esenboğa S, et al. Systemic and large local reactions during
subcutaneous grass pollen immunotherapy in children. Pediatric
Allergy and Immunology. 2020.
24. Kilincel S KO, Muratdagi G, Aydin
A, Usta MB. Factors affecting the anxiety levels of adolescents in
home‐quarantine during COVID‐19 pandemic in Turkey. Asia Pacific
Psychiatry. 2020 Aug 2011;e12406.
25. Götzinger F, Santiago-García B,
Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe:
a multinational, multicentre cohort study. The Lancet Child &
Adolescent Health. 2020.